Top Markets
Coin of the day
Tianjin Tianyao Pharmaceuticals Co., Ltd. Tianjin Tianyao Pharmaceuticals Co., Ltd.

Tianjin Tianyao Pharmaceuticals Co., Ltd.

600488
Rank in Stocks #10130
Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily... Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily engaged in the research, manufacturing, and export of active pharmaceutical ingredients (APIs) across the Asian market. The company's core product offerings include APIs and formulated drugs for corticosteroid, cardio cerebrovascular, and analgesic applications. Its extensive portfolio of bulk drug substances encompasses numerous compounds such as dexamethasone and its various salts and esters, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone and its derivatives, clobetasol propionate, betamethasone, and methylprednisolone. Based in Tianjin, China, Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE: 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.
Share Price
$0.81151775
Last synced: 2026-08-28
Market Cap
$886.09M
Change (1 day)
-1.75%
Change (1 year)
35.84%
Country
CN
Trade Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)

Category

Earnings for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)
Earnings in 2026 TTM: 0
According to Tianjin Tianyao Pharmaceuticals Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Tianjin Tianyao Pharmaceuticals Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors